Biocontainment

Dallas County Health and Human Services opened its new Public Health Laboratory in March of 2026. Strategically sited in the Southwestern Medical District, the $52 million facility offers state-of-the-art environments for the detection and mitigation of infectious agents and toxins. The 67,000-sf building centralizes lab services previously dispersed in several locations while significantly increasing capacity for testing, disease surveillance, and emergency response.

The Ohio State University opened the Multispecies Animal Learning Center (MALC) and a new dairy in Columbus in January of 2026. The $60 million complex was designed by Wellogy as an integrated hub for teaching and research that enables the next generation of animal sciences education. Spanning 100,000 sf, MALC provides the College of Food, Agricultural, and Environmental Sciences with leading-edge classrooms and demonstration areas where students participate in a dynamic pedagogy of experiential engagement.

When it was proposed in 2019, repurposing underutilized space at the University of Georgia for an industry partner’s fermentation lab appeared to be a good deal for everyone involved. It was a win for the pharmaceutical company that wanted to contract with the university to help it develop new products and needed a fermentation lab that met, at a minimum, biosafety level 2 (BSL-2) standards. It was a plus for staff at the university’s Bioexpression and Fermentation Facility who would perform the work. It represented an advance for the university that wanted to form new industry relationships and had available space at its Athens, Ga. campus inside the Animal Health Research Center (AHRC). And it was a win for the AHRC, a 75,000-sf biocontainment facility that would host a new industry partner in addition to other laboratories performing BSL-2, animal biosafety level 2 (ABSL-2), biosafety level 3 (BSL-3), animal biosafety level 3 (ABSL-3), and animal biosafety level 3-agricultural (ABSL-3Ag) research work.

Penn Medicine opened a $376 million facility in September of 2025 in Philadelphia to drive pioneering research in autoimmune disorders. Positioned atop an existing 250,000-sf office tower, the eight-story overbuild features wet laboratories, a vivarium, and a BSL-3 lab for the processing of infectious disease specimens. The 217,000-sf expansion was designed by Perkins&Will to stimulate collaboration and accelerate the development of new treatment modalities for conditions such as arthritis, lupus, diabetes, and multiple sclerosis. 

Masaryk University (MU) is constructing the MUNI BioPharma Hub to drive excellence in research, education, and innovation in Brno in the Czech Republic. Offering three underground levels and six stories above grade, the 163,504-sf project was designed by Pelčák a partner architekti to combine leading-edge scientific infrastructure with modern academic venues.